TAMOVALCIR in Allogenic Hematopoietic Progenitors Transplant

Clinical trial NCT00386412 · COMPLETED

Trial details

NCT number: NCT00386412
Sponsor: PETHEMA Foundation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cytomegalovirus Infection

Start date: 2005-11-01
Primary completion: 2009-09-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.